Comparison of Keppra and Clonidine in the Treatment of Tics

Summary

The goal of this study is to confirm that levetiracetam has a better tic-suppressing profile than that of the widely used tic-suppressing medication, clonidine. More specifically, the investigators hypothesize that in a 15 week placebo run-in, double-blind, medication cross-over trial; levetiracetam will be more effective and have fewer side-effects than clonidine.

Timeline

Start

2007-02

Primary completion

2008-07

Completion

2009-06

Drugs

Indications